Costly IVF add-ons fail to show benefits, new study finds

A new study in The Lancet has found that costly add-on treatments marketed by fertility clinics to boost IVF success rates lack solid scientific evidence. The research suggests many of these premium services don't deliver on their promises, potentially wasting thousands of dollars for couples already facing the high costs of assisted reproduction.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton